Health in Kazakhstan 1,282 indicators covering health for Kazakhstan. IndicatorLatest Year10-yr change Rank Maternal mortality ratio 9.58 per 100,000 live births 2023 down 35.6% 133rd Universal health coverage (UHC) service coverage index, 2025 83 index 2023 up 1.2% 33rd Number of stillbirths 1,765 2023 down 33.8% 81st Hepb3 number unvaccinated 13,052 2023 up 241.8% 94th Rotavirus vaccines completed dose (RotaC) immunization coverage among 0.0% 2025 — 136th Young people (ages 15-24) newly infected with HIV 500 2024 unchanged 55th Tb related deaths hiv 280 2023 up 522.2% 54th Smoking bans in public places 6 2022 up 20.0% 82nd Current health expenditure (CHE) as percentage of gross domestic 3.8% 2023 up 41.5% 159th External health expenditure (EXT) as percentage of current health 0.2% 2023 up 0.4% 121st Domestic general government health expenditure (GGHE-D) as percentage 65.8% 2023 down 5.1% 68th Out-of-pocket expenditure as percentage of current health expenditure 27.6% 2023 up 6.5% 97th Domestic general government health expenditure (GGHE-D) as percentage 2.5% 2023 up 34.3% 110th Domestic general government health expenditure (GGHE-D) as percentage 10.7% 2023 up 14.8% 86th Domestic private health expenditure (PVT-D) as percentage of current 34.0% 2023 up 11.6% 99th Current health expenditure (CHE) per capita in US$ 489.71 2023 up 36.4% 94th Domestic private health expenditure (PVT-D) per capita in US$ 166.43 2023 up 52.3% 92nd Domestic general government health expenditure (GGHE-D) per capita in 322.38 2023 up 29.5% 87th Total healthcare expenditure gdp 3.77 2023 up 41.5% 160th Health expenditure government expenditure 10.7 2023 up 14.8% 87th Mumps - number of reported cases 130 2025 up 420.0% 56th Incidence of tuberculosis (per 100 000 population) 4.3 2023 up 59.3% 64th Hib vaccine 98 2024 up 3.2% 20th Congenital Rubella Syndrome - number of reported cases 0 2025 — 16th External health expenditure (EXT) per capita in US$ 0.8977 2023 up 36.9% 126th Dentists 4,628 2024 down 28.0% 60th People with basic handwashing facilities including soap and water 98.7% 2019 unchanged 6th Nursing and midwifery personnel 136,011 2024 up 9.2% 37th Nursing personnel 127,594 2024 up 10.8% 34th Number of new HIV infections per 1,000 uninfected population, by sex 0.1108 per 1000 uninfected pop 2024 down 30.7% 64th Raised blood pressure (SBP>=140 OR DBP>=90) 29.16 2019 down 12.5% 118th Raised blood pressure (SBP>=140 OR DBP>=90) 28.87 2019 down 10.8% 108th Hypertension: diagnosis coverage among adults aged 30-79 with 83.6% 2019 up 7.2% 1st Hypertension among adults aged 30-79 years, prevalence 41.9 2019 up 1.0% 55th Hypertension effective treatment coverage (controlled hypertension) 30.5% 2019 up 54.0% 32nd Hypertension: effective treatment coverage (controlled hypertension) 30.6% 2019 up 53.8% 32nd Hypertension treatment coverage among adults aged 30-79 with 70.4% 2019 up 14.1% 7th Hypertension treatment coverage among adults aged 30-79 with 70.5% 2019 up 13.0% 4th Hypertension: diagnosis coverage among adults aged 30-79 with 83.6% 2019 up 7.9% 2nd Hypertension among adults aged 30-79 years, prevalence, crude 41.6 2019 up 3.0% 49th Pneumococcal conjugate second or third-dose vaccines (PCVc) 49.0% 2025 down 27.9% 154th People with basic handwashing facilities including soap and water 99.2% 2019 unchanged 4th Adolescent birth rate 0.0175 2023 down 50.3% 135th Rubella number unvaccinated 4,351 2023 up 13.9% 100th Estimated number of malaria cases 0 Cases 2024 — 82nd Treatment success rate: previously treated TB cases 70 2023 up 11.1% 88th Medical doctors 30.59 2024 down 20.9% 58th Proportion of births attended by skilled health personnel 99.9% 2018 up 0.6% 14th Prevalence of insufficient physical activity among adults aged 18+ 28.4% 2022 up 28.3% 83rd Prevalence of insufficient physical activity among adults aged 18+ 28.2% 2022 up 24.6% 84th Nursing and midwifery personnel 66.05 2024 down 5.5% 47th Estimated number of people (all ages) living with HIV 44,000 2025 up 69.2% 64th Prevalence of HIV among adults aged 15 to 49 0.3% 2025 up 50.0% 82nd Cases of paralytic polio from wild vs vaccine derived viruses 0 2023 — 24th Immunization measles vs vaccine safety 92 2024 down 7.1% 56th Share of children vaccinated with mcv2 92 2024 down 7.1% 56th Cases of paralytic polio from vaccine derived viruses 0 2023 — 24th TB patients with known HIV status 98.0% 2024 unchanged 42nd Reported number of people receiving antiretroviral therapy 34,191 2025 up 451.4% 61st Estimated antiretroviral therapy coverage among people living with HIV 79.0% 2025 up 229.2% 57th ← Previous Page 11 of 22 Next →